Peripheral Arterial Disease Market is segmented By Treatment (Drug Therapy, Endovascular Therapy), By Disease (Peripheral Arterial Disease, Pulmonary Vascular Disease), By Patient (Adult, Elderly), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
The major players operating in the peripheral arterial disease market include Novartis, Bayer, Pfizer, Amgen, Sanofi, Novo Nordisk, Helixmith, AdvanceCor, and ViroMed.
Peripheral Arterial Disease Market